bavituximab
oncternal therapeutics,oncxerna therapeutics
['bavituximab', 'oncxerna', 'biotec']
oncxerna therapeutics announces upcoming asco poster featuring data showing the phase 2 glioblastoma trial of bavituximab with chemoradiation and adjuvant temozolomide met its primary endpoint 
We provide a balanced view on small cap biotech equities.